Zhi Yang
- Clinical Biochemistry top 0.5%
- Cancer Research top 5%
- Cancer-related molecular mechanisms research 10
- MicroRNA in disease regulation 5
- Nephrology top 2%
- Molecular Biology top 10%
- RNA modifications and cancer 7
- Circular RNAs in diseases 6
- Retinal Development and Disorders 4
-
- Virus-based gene therapy research 5
-
- Neuropeptides and Animal Physiology 4
-
- Pain Mechanisms and Treatments 4
- Co-authors
- Shengfang GeHelen VlassaraAnthony CeramiRenbing JiaQingfeng ShangZenji MakitaVera DelaneyEdward Y. Skolnik
- Journals
- Research (2 papers)Journal of Translational Medicine (2 papers)Investigative Ophthalmology & Visual Science (2 papers)
- Partner nations
- ChinaUnited StatesJapan
In The Last Decade
Zhi Yang
70 papers receiving 2.4k citations
Hit Papers
Peers
Comparison fields: 5 of 138
- Clinical Biochemistry 757
- Cancer Research 596
- Nephrology 263
- Endocrinology, Diabetes and Metabolism 474
- Molecular Biology 1.0k
Countries citing papers authored by Zhi Yang
This map shows the geographic impact of Zhi Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhi Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhi Yang more than expected).
Fields of papers citing papers by Zhi Yang
This network shows the impact of papers produced by Zhi Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhi Yang. The network helps show where Zhi Yang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Zhi Yang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2024 | 7 | |
| 4 | 2024 | 2 | |
| 5 | 2023 | 4 | |
| 6 | 2023 | 3 | |
| 7 | 2023 | 2 | |
| 8 | 2022 | 9 | |
| 9 | 2022 | 27 | |
| 10 | 2022 | 13 | |
| 11 | 2022 | 74 | |
| 12 | 2022 | 2 | |
| 13 | 2020 | 13 | |
| 14 | 2019 | 90 | |
| 15 | Lipase Production and Optimization from Bioremediation of Disposed Engine Oil | 2017 | 4 |
| 16 | 2014 | 6 | |
| 17 | 2013 | 15 | |
| 18 | Exploring U.S Cropland - A Web Service based Cropland Data Layer Visualization, Dissemination and Querying System (Invited) | 2010 | 1 |
| 19 | 2008 | 42 | |
| 20 | Advanced Glycosylation End Products in Patients with Diabetic Nephropathybreakdown → | 1991 | 740 |
About Zhi Yang
Zhi Yang is a scholar working on Health Informatics, Cancer Research, Physiology, Immunology and Allergy and Molecular Biology, having authored 72 papers that have together received 2.5k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (10 papers), RNA modifications and cancer (7 papers), Circular RNAs in diseases (6 papers), Virus-based gene therapy research (5 papers), MicroRNA in disease regulation (5 papers), Neuropeptides and Animal Physiology (4 papers), Pain Mechanisms and Treatments (4 papers) and Retinal Development and Disorders (4 papers). The work is most often cited by research in Clinical Biochemistry (757 citations), Cancer Research (596 citations), Nephrology (263 citations), Endocrinology, Diabetes and Metabolism (474 citations) and Molecular Biology (1.0k citations). Zhi Yang has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Shengfang Ge, Helen Vlassara, Anthony Cerami, Renbing Jia, Qingfeng Shang, Zenji Makita, Vera Delaney, Edward Y. Skolnik, Elliot J. Rayfield and Steven Radoff. Their work appears in journals such as Research, Journal of Translational Medicine, Investigative Ophthalmology & Visual Science, Frontiers in Oncology and European Journal Of Oral Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.